X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare JUBILANT LIFE SCIENCES with Dishman Pharma - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

JUBILANT LIFE SCIENCES vs DISHMAN PHARMA - Comparison Results

DISHMAN PHARMA 
   Change

Dishman Pharmaceuticals is involved in the manufacture of APIs (active pharmaceutical ingredients), intermediates, quaternary compounds and fine chemicals. Besides this, the company is a significant player in the CRAMS (Contract Research and Manufact... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    JUBILANT LIFE SCIENCES DISHMAN PHARMA JUBILANT LIFE SCIENCES/
DISHMAN PHARMA
 
P/E (TTM) x 27.4 25.1 109.4% View Chart
P/BV x 5.6 3.3 168.3% View Chart
Dividend Yield % 0.3 0.7 48.6%  

Financials

 JUBILANT LIFE SCIENCES   DISHMAN PHARMA
EQUITY SHARE DATA
    JUBILANT LIFE SCIENCES
Mar-14
DISHMAN PHARMA
Mar-16
JUBILANT LIFE SCIENCES/
DISHMAN PHARMA
5-Yr Chart
Click to enlarge
High Rs187374 49.9%   
Low Rs65129 50.5%   
Sales per share (Unadj.) Rs364.3197.8 184.2%  
Earnings per share (Unadj.) Rs6.821.2 32.3%  
Cash flow per share (Unadj.) Rs24.534.7 70.6%  
Dividends per share (Unadj.) Rs3.002.00 150.0%  
Dividend yield (eoy) %2.40.8 299.7%  
Book value per share (Unadj.) Rs164.9179.9 91.7%  
Shares outstanding (eoy) m159.2880.69 197.4%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x0.31.3 27.2%   
Avg P/E ratio x18.411.9 155.0%  
P/CF ratio (eoy) x5.17.2 70.9%  
Price / Book Value ratio x0.81.4 54.6%  
Dividend payout %43.89.4 464.6%   
Avg Mkt Cap Rs m20,06120,306 98.8%   
No. of employees `0006.20.8 746.1%   
Total wages/salary Rs m11,0525,355 206.4%   
Avg. sales/employee Rs Th9,383.019,252.7 48.7%   
Avg. wages/employee Rs Th1,786.96,459.5 27.7%   
Avg. net profit/employee Rs Th176.32,064.1 8.5%   
INCOME DATA
Net Sales Rs m58,03415,961 363.6%  
Other income Rs m191265 71.8%   
Total revenues Rs m58,22416,226 358.8%   
Gross profit Rs m5,7864,103 141.0%  
Depreciation Rs m2,8121,091 257.8%   
Interest Rs m3,237944 342.8%   
Profit before tax Rs m-722,334 -3.1%   
Minority Interest Rs m-2860-   
Prior Period Items Rs m01 0.0%   
Extraordinary Inc (Exp) Rs m2,1450-   
Tax Rs m696624 111.7%   
Profit after tax Rs m1,0901,711 63.7%  
Gross profit margin %10.025.7 38.8%  
Effective tax rate %-965.926.7 -3,614.5%   
Net profit margin %1.910.7 17.5%  
BALANCE SHEET DATA
Current assets Rs m29,28011,018 265.8%   
Current liabilities Rs m38,9129,517 408.9%   
Net working cap to sales %-16.69.4 -176.5%  
Current ratio x0.81.2 65.0%  
Inventory Days Days84110 76.4%  
Debtors Days Days5135 145.5%  
Net fixed assets Rs m55,71216,304 341.7%   
Share capital Rs m155161 95.7%   
"Free" reserves Rs m20,96812,907 162.5%   
Net worth Rs m26,26514,516 180.9%   
Long term debt Rs m17,1694,189 409.8%   
Total assets Rs m88,60629,805 297.3%  
Interest coverage x1.03.5 28.2%   
Debt to equity ratio x0.70.3 226.5%  
Sales to assets ratio x0.70.5 122.3%   
Return on assets %4.98.9 54.8%  
Return on equity %4.211.8 35.2%  
Return on capital %11.617.5 66.0%  
Exports to sales %37.824.8 152.5%   
Imports to sales %16.53.7 441.3%   
Exports (fob) Rs m21,9333,956 554.4%   
Imports (cif) Rs m9,567596 1,604.4%   
Fx inflow Rs m22,0044,952 444.4%   
Fx outflow Rs m11,749697 1,686.1%   
Net fx Rs m10,2554,255 241.0%   
CASH FLOW
From Operations Rs m8,0262,786 288.0%  
From Investments Rs m-1,744-1,529 114.1%  
From Financial Activity Rs m-4,447-941 472.6%  
Net Cashflow Rs m1,834316 579.8%  

Share Holding

Indian Promoters % 45.6 61.4 74.3%  
Foreign collaborators % 3.5 0.0 -  
Indian inst/Mut Fund % 8.7 3.7 235.1%  
FIIs % 21.2 12.7 166.9%  
ADR/GDR % 0.0 0.0 -  
Free float % 21.1 22.1 95.5%  
Shareholders   23,815 46,261 51.5%  
Pledged promoter(s) holding % 15.9 35.8 44.3%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare JUBILANT LIFE SCIENCES With:   STERLING BIOTECH  SANOFI INDIA  DR. DATSONS LABS  ORCHID PHARMA LTD  NOVARTIS  

Compare JUBILANT LIFE SCIENCES With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Global Stock Markets Rebound After Sharp Weekly Drop(RoundUp)

Global financial markets rallied this week and brushed aside a rise in global borrowing costs while the dollar hit its lowest level since 2014.

Related Views on News

Most Popular

Here's What You Should Do in this Market Crash(The 5 Minute Wrapup)

Feb 6, 2018

The market correction has provided a golden opportunity to buy five high-quality safe stocks.

As the Market Corrects... It's Time to Buy More(Smart Contrarian)

Feb 5, 2018

The recent sell off in the stock market offers buying opportunity in some quality small caps.

The Era of Easy Money is Coming to an End. What Happens Now?(Vivek Kaul's Diary)

Feb 9, 2018

The easy money policy of the Federal Reserve of the United States, which drove up stock markets all over the world, is ending, with the Federal Reserve looking to shrink its balance sheet.

When Small is Not Always Beautiful(Chart Of The Day)

Feb 6, 2018

Big companies enjoying tax deductions and exemptions have an edge over the small companies.

What Should Mutual Fund Investors Do After LTCG Tax Norms(Outside View)

Feb 6, 2018

PersonalFN explain what investors should after LTCG tax norms.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

JUBILANT LIFE SCIENCES SHARE PRICE


Feb 16, 2018 (Close)

TRACK JUBILANT LIFE SCIENCES

  • Track your investment in JUBILANT LIFE SCIENCES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON JUBILANT LIFE SCIENCES

JUBILANT LIFE SCIENCES - FRESENIUS KABI ONCO. COMPARISON

COMPARE JUBILANT LIFE SCIENCES WITH

MARKET STATS